Evidence map›Paper›PMID 29069996›Full record

ReviewDrug delivery2017

Transporting carriers for intracellular targeting delivery via non-endocytic uptake pathways.

Zuhong Li, Yanhong Zhang, Danhua Zhu, Shuiqing Li, Xiaopeng Yu, Yalei Zhao, Xiaoxi Ouyang, Zhongyang Xie, Lanjuan Li

Abstract readReview
In one paragraph

Review in Drug delivery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Translocation of TiRSC advances · 2024
    Article
  5. Article
  6. Article
  7. Advances in nanomaterial-based targeted drug delivery systems.Frontiers in bioengineering and biotechnology · 2023
    Review
  8. Article
  9. Cell-Penetrating Peptides.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zuhong Lia State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases , The First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou , PR China.
Yanhong Zhanga State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases , The First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou , PR China.
Danhua Zhua State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases , The First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou , PR China.
Shuiqing Lia State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases , The First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou , PR China.
Xiaopeng Yua State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases , The First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou , PR China.
Yalei Zhaoa State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases , The First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou , PR China.
Xiaoxi Ouyanga State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases , The First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou , PR China.
Zhongyang Xiea State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases , The First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou , PR China.
Lanjuan Lia State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases , The First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou , PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To develop novel therapies for clinical treatments, it increasingly depends on sophisticated delivery systems that facilitate the drugs entry into targeting cells. Profound understanding of cellular uptake routes for transporting carriers promotes the optimization of performance in drug delivery systems. Although endocytic pathway is the most important part of cellular uptake routes for many delivery systems, it suffers the trouble of enzymatic degradation of transporting carriers trapped in endosomes/lysosomes. Therefore, it is desirable to develop alternative transporting methods for delivery systems via non-endocytic pathways to achieve more effective intracellular delivery. In this review, we summarize the literature exploring transporting carriers that mediate intracellular delivery via non-endocytic pathways to present the current research status in this field. Cell-penetrating peptides, pH (low) insertion peptides, and nanoparticles are categorized to exhibit their ability to directly transport various cargos into cytoplasm via non-endocytic uptake in different cell lines. It is hoped that this review can spur the interesting on development of drug delivery systems via non-endocytic uptake pathway.

Indexed as

Biological TransportCell-Penetrating PeptidesDrug CarriersDrug Delivery SystemsEndocytosisEndosomesHumansNanoparticlesCell-Penetrating PeptidesDrug Carriersdelivery systemsinternalization mechanismintracellular deliverynon-endocytic uptakeTransporting carriers

Identifiers

PMID29069996
PMCPMC8812582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.